BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4205659)

  • 1. Role of a myocardial depressant factor in shock states.
    Lefer AM
    Mod Concepts Cardiovasc Dis; 1973 Dec; 42(12):59-64. PubMed ID: 4205659
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
    Lefer AM
    Fed Proc; 1970; 29(6):1836-47. PubMed ID: 5482718
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
    Lefer AM
    Prog Clin Biol Res; 1983; 111():111-23. PubMed ID: 6191336
    [No Abstract]   [Full Text] [Related]  

  • 4. The lysosomal protease--myocardial depressant factor system in circulatory shock.
    Lefer AM; Glenn TM
    Adv Exp Med Biol; 1972; 33(0):367-73. PubMed ID: 4672015
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of cardioinhibitory factors produced in shock.
    Lefer AM
    Fed Proc; 1978 Nov; 37(13):2734-40. PubMed ID: 361437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive feedback actions of a myocardial depressant factor in circulatory shock.
    Lefer AM
    Tex Rep Biol Med; 1979; 39():209-16. PubMed ID: 553307
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of the myocardial depressant factor in the pathogenesis of the shock].
    Pagni E
    Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lysosomal enzymes in shock. Theoretical and experimental foundations, their significance in clinical diagnosis and therapy II].
    Horpácsy G; Schnells G
    Med Welt; 1980 Dec; 31(51-52):1859-61. PubMed ID: 6162072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protease activity in shock. Indications for Trasylol-R therapy].
    Halvorsen KA
    Tidsskr Nor Laegeforen; 1966 May; 86(9):681-3. PubMed ID: 5296733
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myocardial depressant factor in shock].
    Okada K; Kosugi I; Yamaguchi Y; Innami H; Kawashima Y
    Masui; 1973 May; 22(5):414-22. PubMed ID: 4737987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanisms that inhibit the formation and manifestation of the myocardial depressant factor in shock states].
    Lefer AM
    Khirurgiia (Sofiia); 1980; 33(5):377-85. PubMed ID: 7003214
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial depressant factor and circulatory shock.
    Lefer AM
    Klin Wochenschr; 1974 Apr; 52(8):358-70. PubMed ID: 4414760
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of lysosomes in circulatory shock.
    Lefer AM
    Life Sci; 1976 Dec; 19(12):1803-9. PubMed ID: 794609
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical characterization of a positive inotropic plasma factor in shock.
    Szabó I; Penke B; Kaszaki J; Nagy S
    Prog Clin Biol Res; 1989; 308():253-7. PubMed ID: 2675050
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic hydrolases and the formation of a myocardial depressant factor in shock.
    Lefer AM; Barenholz Y
    Am J Physiol; 1972 Nov; 223(5):1103-9. PubMed ID: 4540125
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity.
    Spilberg I; Mandell B; Wochner RD
    J Lab Clin Med; 1974 Jan; 83(1):56-63. PubMed ID: 4543439
    [No Abstract]   [Full Text] [Related]  

  • 18. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification of a reticuloendothelial system-depressing substance produced in shock.
    Blattberg B; Frosolono MF; Misra RP; Levy MN
    J Reticuloendothel Soc; 1972 Oct; 12(4):371-86. PubMed ID: 4634517
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.